Evidence map›Paper›PMID 28568169›Full record

Trial reportJournal of veterinary internal medicine2017

Effect of Dexamethasone and Fluticasone on Airway Hyperresponsiveness in Horses With Inflammatory Airway Disease.

R Léguillette, T Tohver, S L Bond, J A Nicol, K J McDonald

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of veterinary internal medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Glucocorticoid treatment in horses with asthma: A narrative review.Journal of veterinary internal medicine · 2021
    Review
  4. Treatment of naturally occurring asthma with inhaled fluticasone or oral prednisolone: A randomized pilot trial.Canadian journal of veterinary research = Revue canadienne de recherche veterinaire · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Alkaloids fromMolecules (Basel, Switzerland) · 2018
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

R LéguilletteFaculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada.ORCID http://orcid.org/0000-0003-0381-3640
T TohverFaculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada.
S L BondFaculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada.ORCID http://orcid.org/0000-0002-6700-5127
J A NicolFaculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada.
K J McDonaldFaculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada.
University of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAirway hyperresponsiveness (AWHR), expressed as hypersensitivity (PC

objectivesTo determine whether dexamethasone (DEX) (0.05 mg/kg IM q24h) and inhaled fluticasone (FLUT) (3,000 μg q12h) administered by inhalation are effective in decreasing AWHR, lung inflammation, and clinical signs in horses with IAD.

methodsA randomized crossover study design was used. Eight horses with IAD were assigned to a treatment group with either DEX or FLUT. Measured outcomes included lung mechanics during bronchoprovocative challenges, bronchoalveolar lavage fluid (BALF) cytology, and scoring of clinical signs during exercise.

resultsDexamethasone and FLUT abolished the increase in R CONCLUSIONS AND CLINICAL IMPORTANCE: Both DEX and FLUT treatments significantly inhibit airway hypersensitivity and hyperreactivity in horses with IAD. There are no significant effects on the clinical signs or the number of inflammatory cells (except lymphocytes) in BALF. The treatments have no residual effect 3 weeks after discontinuation.

Indexed as

AnimalsAnti-Inflammatory AgentsAsthmaBronchial Provocation TestsBronchoalveolar Lavage FluidCross-Over StudiesDexamethasoneFemaleFluticasoneHorse DiseasesHorsesMaleRespiratory Function TestsRespiratory HypersensitivityAnti-Inflammatory AgentsDexamethasoneFluticasoneAirway hyperreactivityAirway hypersensitivityBronchoalveolar lavageEquine asthmaHistamine bronchoprovocation challengeRespiratory clinical signs

Identifiers

PMID28568169
PMCPMC5508307
OpenAlexW2621250425

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.